Schrödinger, Inc. (SDGR) stock declined over -3.14%, trading at $12.94 on NASDAQ, down from the previous close of $13.36. The stock opened at $12.98, fluctuating between $12.94 and $13.41 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 05, 2026 | 12.98 | 13.41 | 12.94 | 12.94 | 1.76M |
| Feb 04, 2026 | 13.30 | 13.46 | 12.89 | 13.36 | 1.44M |
| Feb 03, 2026 | 14.12 | 14.43 | 12.96 | 13.38 | 1.59M |
| Feb 02, 2026 | 13.88 | 14.32 | 13.67 | 14.09 | 1.26M |
| Jan 30, 2026 | 14.06 | 14.08 | 13.44 | 13.97 | 2.58M |
| Jan 29, 2026 | 14.43 | 14.61 | 14.08 | 14.32 | 1.39M |
| Jan 28, 2026 | 14.91 | 14.99 | 14.56 | 14.57 | 1.68M |
| Jan 27, 2026 | 15.57 | 15.88 | 14.79 | 14.88 | 1.91M |
| Jan 26, 2026 | 16.25 | 16.31 | 15.52 | 15.53 | 1.71M |
| Jan 23, 2026 | 17.43 | 17.43 | 16.38 | 16.42 | 1.15M |
| Jan 22, 2026 | 16.68 | 17.87 | 16.65 | 17.33 | 1.46M |
| Jan 21, 2026 | 16.35 | 16.75 | 16.07 | 16.42 | 1.12M |
| Jan 20, 2026 | 16.32 | 16.68 | 16.20 | 16.32 | 1.2M |
| Jan 16, 2026 | 17.53 | 17.53 | 16.61 | 16.79 | 1.12M |
| Jan 15, 2026 | 18.34 | 18.34 | 17.15 | 17.47 | 1.18M |
| Jan 14, 2026 | 18.20 | 18.47 | 17.98 | 18.33 | 646.06K |
| Jan 13, 2026 | 18.69 | 18.72 | 18.17 | 18.31 | 594.5K |
| Jan 12, 2026 | 18.54 | 18.71 | 18.16 | 18.64 | 731.07K |
| Jan 09, 2026 | 18.83 | 18.85 | 18.27 | 18.39 | 1.05M |
| Jan 08, 2026 | 18.71 | 18.74 | 18.05 | 18.61 | 790.88K |
Schr�dinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schr�dinger, Inc. was incorporated in 1990 and is based in New York, New York.
| Employees | 891 |
| Beta | 1.54 |
| Sales or Revenue | $216.67M |
| 5Y Sales Change% | 1.195% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep